Genomines
Latest round
- Series A
Last raised
- Sep 2025
Total raised
- $42M
Investors
- 17
About Genomines
Genomines, based in France, is a company dedicated to leveraging synthetic biology for the bioextraction of nickel from contaminated environments.Established in Paris, France, in 2021, Genomines focuses on enhancing natural biology through synthetic biology to facilitate the extraction of nickel from contaminated soils.Genomines specializes in utilizing synthetic biology to enhance plants' natural biology for the sustainable extraction of nickel from contaminated soils, including mine tailings and fields with excessive heavy metals. The company’s core product offering revolves around bioextraction techniques, which improve the ability of plants to absorb nickel efficiently and economically while simultaneously remediating land. This process, often referred to as "phytomining," aims to address the growing demand for nickel, projected to increase significantly due to the energy transition and the need for critical metals in battery production.Genomines generates revenue through strategic partnerships and collaborations with industries requiring sustainable nickel. Transactions typically occur through B2B arrangements, where clients engage the company for its bioextraction services as part of broader sustainability initiatives. The revenue model may include project-based fees for specific extraction and remediation projects, providing clients with an innovative, cost-effective solution to their metal sourcing needs. The company is also planning to expand its operations into new geographic markets, particularly targeting regions in North America and Asia by 2026.
Who invested in Genomines
17 investors across 2 rounds
See all investors in Genomines
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Genomines
Who invested in Genomines?
Genomines has 17 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Genomines raised?
Genomines has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Genomines last raise money?
Genomines's most recent round on record is a Series A, in Sep 2025.
What does Genomines do?
Genomines, based in France, is a company dedicated to leveraging synthetic biology for the bioextraction of nickel from contaminated environments.
Where is Genomines headquartered?
Genomines is headquartered in Paris, France.
Which VCs invest in companies like Genomines?
Among active investors with capital left to deploy, Mundi Ventures, Partech Partners, Mirova and Anterra Capital back materials companies at Genomines's stage. Their profiles are linked below.
VCs backing materials startups at Series A
Raising like Genomines? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.